Navigation Links
Picofemto Deploys Cloud-Based Cliniscan EEG Analytics and Clinical Decision Support
Date:10/19/2013

NEW YORK, Oct. 17, 2013 /PRNewswire-iReach/ -- Picofemto LLC, a biomedical software company specializing in neuroanalytics and personalized medicine, is pleased to announce the deployment of its first product, EEG Decision Support, based on its proprietary cloud-based biomedical engine, CliniscanTM.

(Photo: http://photos.prnewswire.com/prnh/20131017/MN99127)

CliniscanTM, the innovative web-based software as a service (SaaS) platform, provides rapid analysis of complex biomedical data to support clinical decisions by physicians.  In addition, Picofemto's open-standards base design emphasizes security, anonymity, and trust, while enabling partnerships for third party diagnostic algorithms with its dynamic open API. The easy-to-use-web interface addresses the medical community and removes the burden of data manipulation and storage while enhancing interoperability for the physician and the patient.

The product immediately benefits healthcare professionals and institutions, particularly in the neurology field, by providing software that integrates multiple biomedical modalities (EEG, MRI, CT), into a single package that can efficiently process complex data – including quantitative EEG analysis and brain segmentation.  Additionally, CliniscanTM will permit the storage, retrieval, and sharing of digital biomedical files, including DICOM. A number of studies have demonstrated that the primary driver increasing healthcare costs is technology.  Kai Matsumiya, Chief Operating Officer, states "This technology will lower healthcare costs by decreasing both time and cost while increasing efficiency."

The core of the CliniscanTM platform is a custom engine that divides workloads dynamically across a number of computing nodes. This greatly reduces the time required to analyze data sets and to run workflows that are beyond the capabilities of desktop systems.  According to Brian Kennedy, Chief Technology Officer, "The CliniscanTM toolkit accelerates the development of medical data processing algorithms and reduces the complexity of developing parallel distributed code for cloud processing." Brad Johnson, Lead Developer, describes the open API as "providing third party access to partners with scalability to handle complex data." For these reasons, CliniscanTM stands to become the premier open-architecture, self-proliferating repository for third-party diagnostic algorithms.

EEG Decision Support, the first plug-in modality within the CliniscanTM open architecture, is the most comprehensive product of its kind available in the market. Fatih Sirin, Ph.D and Head of Analytics, notes"EEG Decision Support addresses the paramount components of quantitative EEG analysis - insomnia, dementia, epilepsy, head injury, sleep apnea, using an array of "gold standard" algorithms."  Dhinakaran Chinappen, Biomedical Engineer, reports "EEG Decision Support features automated spike detection, seizure detection, classification, thereby saving the physician a substantial amount of time."

Cecily Xi and William Bubel, Senior Software Engineers, emphasize that "Users are provided with a complete, comprehensive, and objective report conveying abnormal characteristics of the EEG recording, clinical correlations, and notes from the physician."  

Picofemto distinguishes itself with the ability to process large scale biomedical data in an efficient manner - within the medical sector which has experienced unprecedented high costs and increased volume. Robert Callan, Quantitative Analyst, is excited about "a wider range of analytics for biomedical modalities including ECG, MRI, CT, and PET that will be deployed in the near future." In addition, because of its cloud-based delivery, Picofemto is planning for international expansion within both the developing and developed world contexts where many would reap the benefits of a critical healthcare component.   

Srikant Krishna, Founder & CEO, states "We are very pleased to have developed this sophisticated product on a very aggressive schedule since inception.  We strongly feel this will be a game-changer in the utilization of technology in healthcare."  There are expected to be significant changes in the healthcare system and practices derived from the Affordable Care Act ("Obamacare").

For more information, please contact Kai Matsumiya at (kai@picofemto.com, +1.212.502.3770). 

Media Contact: Kai Matsumiya, Picofemto, +1.212.502.3770, kai@picofemto.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Picofemto LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. US Navy Deploys Mobile Biometric Solution Provided by Aware
2. Keeneland Project deploys new GPU supercomputing system for the National Science Foundation
3. Westpak Deploys Horizontal Impact Test System (HITS)
4. CDS Monarch Deploys DigitalPersona Strong Authentication Solutions for Secure Access to Electronic Medical Records
5. Desert Research Institute utilizing IBM big data analytics to assist Nevadas growth strategy
6. UNLV, Sen. Reid Announce $20 Million NIH grant to support clinical health research
7. Wistar receives $1.5 million Department of Defense grant to ready prostate drug for clinical use
8. DO-HEALTH a multi-center clinical trial on healthy ageing achieves first milestone
9. With early, obvious benefit of a targeted cancer drug, should expensive clinical testing continue?
10. Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators
11. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... AWRE ), a leading supplier of biometrics software ... year ended December 31, 2016. Revenue for ... $6.9 million in the same quarter last year. Operating income ... to $2.6 million in the fourth quarter of 2015. Net ... or $0.02 per diluted share, which compares to $1.8 million, ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... and SAN FRANCISCO , Feb. ... regenerative medicine company, and Beyond Type 1, a not-for-profit ... 1 diabetes, today announced a grant from Beyond Type ... cure for type 1 and other insulin-requiring diabetes.  ... been developing innovative stem cell-derived cell replacement therapies with ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , ... Research Systems, LLC (KRS) clinical development program. KRS is a neurotechnology spin-out ... research and clinical applications. The terms of the transaction were not disclosed. ...
(Date:2/22/2017)... 2017 Scientists propose in Nature ... in Gaucher and maybe other lysosomal storage diseases as ... than current therapies. An international research team ... which also included investigators from the University of L├╝beck ... Feb. 22. The study was conducted in mouse models ...
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , ... from around the world, is pleased to announce the 2nd annual Precision Medicine ... This premier, online-only conference focused on the development and advancements in precision medicine. ...
Breaking Biology Technology: